Practice patterns of stroke screening and hydroxyurea use in children with sickle cell disease: A survey of health care providers

Journal of Pediatric Hematology/Oncology

Volumn 36, Issue 6, 2014, Pages

  Madden, Nicholas A ^a   Jones, Gary L ^a   Kalpatthi, Ram ^a   Woods, Gerald ^a  

^a CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

cerebrovascular accident; hydroxyurea; sickle cell disease; stroke; transcranial Doppler ultrasound

Indexed keywords

HYDROXYUREA;

BRAIN INFARCTION; CANADA; CEREBROVASCULAR ACCIDENT; CHILD HEALTH CARE; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; HEALTH CARE PERSONNEL; HEALTH CARE PRACTICE; HEALTH CARE SURVEY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SICKLE CELL ANEMIA; UNITED STATES;

ACUTE CHEST SYNDROME; ADOLESCENT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC TESTING; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEMOGLOBIN, SICKLE; HUMANS; HYDROXYUREA; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MORBIDITY; PHYSICIAN'S PRACTICE PATTERNS; STROKE;

EID: 84905095597     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000160     Document Type: Review

References (25)

1. Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates: A contemporary geostatistical model-based map and population estimates. Lancet. 2013; 381:142-151.
2. National Heart, Lung, and Blood Institute, National Institutes of Health. The Management of Sickle Cell Disease (NIH Publication No. 02-2117). Available at: Http://www.nhlbi. nih.gov/health/prof/blood/sickle/. 2002.
3. Schoenberg BS, Mellinger JF, Schoenberg DG. Cerebrovascular disease in infants and children: A study of incidence, clinical features, and survival. Neurology. 1978;28:763-768.
4. Broderick J, Talbot GT, Prenger E, et al. Stroke in children within a major metropolitan area: The surprising importance of intracerebral hemorrhage. J Child Neurol. 1993;8:250-255.
5. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood. 1998;91:288-294.
6. Russell MO, Goldberg HI, Hodson A, et al. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood. 1984;63: 162-169.
7. Adams RJ, Aaslid R, el Gammal T, et al. Detection of cerebral vasculopathy in sickle cell disease using transcranial Doppler ultrasonography and magnetic resonance imaging. Stroke. 1988;19:518-520.
8. Adams RJ, Nichols FT III, Aaslid R, et al. Cerebral vessel stenosis in sickle cell disease: Criteria for detection by transcranial Doppler. Am J Pediatr Hematol Oncol. 1990; 12:277-282.
9. Adams R, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326:605-610.
10. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5-11.
11. DeBaun MR, Armstrong FD, McKinstry RC, et al. Silent cerebral infarcts: A review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood. 2012;119: 4587-4596.
12. Kwiatkowski JL, Zimmerman RA, Pollock AN, et al. Silent infarcts in young children with sickle cell disease. Br J Haematol. 2009;146:300-305.
13. Collaborator is National Institute of Neurological Disorders and Stroke (NINDS). Sponsor is Washington University School of Medicine. PI: Michael DeBaun, Vanderbilt University. Available at: Http://www.clinicaltrials.gov/ct2/ show/NCT000 72761?term%20=%20silent%20+%20infarct&rank%20=%202. Accessed February 1, 2013.
14. Kratovil T, Bulas D, Driscoll MC, et al. Hydroxyurea therapy lowers TCD velocities in children with sickle cell disease. Pediatr Blood Cancer. 2006;47:894-900.
15. Zimmerman SA, Schultz WH, Burgett S, et al. Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia. Blood. 2007;110:1043-1047.
16. Ali SB, Moosang M, King L, et al. Stroke recurrence in children with sickle cell disease treated with hydroxyurea following first clinical stroke. Am J Hematol. 2011;86:846-850.
17. Gulbis B, Haberman D, Dufour D, et al. Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: The Belgian experience. Blood. 2005;105:2685-2690.
18. Ware RE, Zimmerman SA, Sylvestre PB, et al. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. J Pediatr. 2004;145:346-352.
19. Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children: A scientific statement from a special writing group of the American Heart Association Stroke Council and the Counsel on Cardiovascular Disease in the Young. Stroke. 2008;39:2644-2691.
20. Ware R, Helms R. Stroke with transfusions changing to hydroxyurea (SWiTCH). Blood. 2012;119:3925-3932.
21. Eckrich MJ, Wang WC, Yang E, et al. Adherence to transcranial Doppler screening guidelines among children with sickle cell disease. Pediatr Blood Cancer. 2013;60:270-274.
22. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332:1317-1322.
23. Wang WC, Ware RE, Miller ST, et al. A multicenter randomized controlled trial of hydroxyurea (hydroxycarbamide) in very young children with sickle cell anaemia. Lancet. 2011;377:1663-1672.
24. Ferster A, Tahriri P, Vermylen C, et al. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood. 2001;97:3628-3632.
25. McCavit TL, Xuan L, Zhang S, et al. National trends in incidence rates of hospitalization for stroke in children with sickle cell disease. Pediatr Blood Cancer. 2013;60:823-827.